There are plenty of reasons to invest in life settlements. This alternative investment has developed due to a unique necessity. In fact, it has caused a positive impact for both institutional investors and the insured individual. The prolonged low-interest-rate environment is forcing investors to embark on paths away from traditional assets as they seek a […]
It seems that fake news has been a hot topic lately. Even the life settlements market isn’t immune. We sometimes see published returns that seem too good to be true. We fear that some of these rely on valuation assumptions rather than actual realised returns. Headlines that report solely positive or smooth regular returns are […]
What if the fund had a poor performance to date, what then? To begin, let’s examine some insightful statistics for our open-ended Irish regulated investment structure. The fund holds a pool of “seasoned” policies. Below, we have included the most current age spread for the GIS General Fund with policies awaiting maturity. Notably, a significant […]
Establishing the correct methodology in estimating gross market return is a common discussion for the life settlements asset class. The science around medical underwriting continues to evolve in the dynamic environment of human longevity. The discussion around appropriate methodologies for uniform financial analysis is timely, post GFC environment. Given the lack of suitable robust analysis […]
